#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	14944	16S	1529	1529	99.87	16S.l15.c4.ctg.1	2182	681.6	0	.	n	.	0	A69G	SNP	69	69	A	320	320	G	854	G	773	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	14944	16S	1529	1529	99.87	16S.l15.c4.ctg.1	2182	681.6	0	.	n	.	0	C1450T	SNP	1450	1450	C	1701	1701	T	868	T	789	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	14944	16S	1529	1529	99.87	16S.l15.c4.ctg.1	2182	681.6	1	SNP	n	C1184T	0	.	.	1184	1184	C	1435	1435	C	883	C	814	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	14944	16S	1529	1529	99.87	16S.l15.c4.ctg.1	2182	681.6	0	HET	.	.	.	C1525T	.	1525	1525	C	1776	1776	C	765	C,T	497,194	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	27816	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3588	772.9	0	.	n	.	0	T695C	SNP	695	695	T	1012	1012	C	863	C,T	788,2	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	27816	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3588	772.9	0	.	n	.	0	T1971C	SNP	1971	1971	T	2288	2288	C	871	C,T	784,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	27816	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3588	772.9	1	SNP	n	A2045G	0	.	.	2045	2045	A	2362	2362	A	868	A	801	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	27816	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3588	772.9	1	SNP	n	C2597T	0	.	.	2597	2597	C	2914	2914	C	846	C,A	773,1	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
blaTEM.WHO_M_pConjugative_00003	blaTEM.WHO_M_pConjugative_00003	1	0	16	16	blaTEM	861	324	100.0	blaTEM.l15.c4.ctg.1	324	2.7	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Betalactam resistance
folP.WHO_O_01412c	folP.WHO_O_01412c	1	1	27	2106	folP	855	855	100.0	folP.l15.c17.ctg.1	1362	153.2	1	SNP	p	R229S	1	.	.	685	687	AGC	940	942	AGC	199;200;199	A;G;C	187;185;184	folP.WHO_O_01412c:1:1:R229S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	5944	gyrA	2751	2751	100.0	gyrA.l15.c17.ctg.1	3435	172.5	1	SNP	p	S91F	1	.	.	271	273	TTC	524	526	TTC	190;192;190	T;T;C	175;175;174	gyrA.WHO_M_01098:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	5944	gyrA	2751	2751	100.0	gyrA.l15.c17.ctg.1	3435	172.5	1	SNP	p	G95N	0	.	.	283	285	GGC	536	538	GGC	186;185;183	G;G;C	170;170;167	gyrA.WHO_M_01098:1:1:G95N:gyrA.95N:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	5944	gyrA	2751	2751	100.0	gyrA.l15.c17.ctg.1	3435	172.5	1	SNP	p	D95G	1	.	.	283	285	GGC	536	538	GGC	186;185;183	G;G;C	170;170;167	gyrA.WHO_M_01098:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
mtrR.WHO_U_01459	mtrR.WHO_U_01459	1	1	539	1788	mtrR	633	633	99.84	mtrR.l15.c30.ctg.1	1188	150.1	0	.	p	.	0	D79N	NONSYN	235	237	GAT	444	446	AAT	200;201;198	A;A;T	187;186;186	.	.
mtrR.WHO_U_01459	mtrR.WHO_U_01459	1	1	539	1788	mtrR	633	633	99.84	mtrR.l15.c30.ctg.1	1188	150.1	1	SNP	p	G45D	0	.	.	133	135	GGC	342	344	GGC	217;215;216	G;G;C	201;196;197	mtrR.WHO_U_01459:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	790	mtrR_promoter	250	250	99.6	mtrR_promoter.l15.c4.ctg.1	1009	78.1	0	.	n	.	0	A197.	DEL	197	197	A	529	529	A	210	A	186	.	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	539	5190	parC	2304	2304	99.87	parC.l15.c4.ctg.1	2837	182.0	0	.	p	.	0	E91G	NONSYN	271	273	GAG	499	501	GGG	212;211;212	G;G;G	201;200;201	.	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	539	5190	parC	2304	2304	99.87	parC.l15.c4.ctg.1	2837	182.0	1	SNP	p	D86N	0	.	.	256	258	GAC	484	486	GAC	201;201;202	G;A;C	187;185;187	parC.WHO_M_00204c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	539	5190	parC	2304	2304	99.87	parC.l15.c4.ctg.1	2837	182.0	1	SNP	p	S87I	0	.	.	259	261	AGT	487	489	AGT	205;208;207	A;G;T	192;193;193	parC.WHO_M_00204c:1:1:S87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	539	5190	parC	2304	2304	99.87	parC.l15.c4.ctg.1	2837	182.0	1	SNP	p	S87R	0	.	.	259	261	AGT	487	489	AGT	205;208;207	A;G;T	192;193;193	parC.WHO_M_00204c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	539	5190	parC	2304	2304	99.87	parC.l15.c4.ctg.1	2837	182.0	1	SNP	p	S87W	0	.	.	259	261	AGT	487	489	AGT	205;208;207	A;G;T	192;193;193	parC.WHO_M_00204c:1:1:S87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	539	5190	parC	2304	2304	99.87	parC.l15.c4.ctg.1	2837	182.0	1	SNP	p	S88P	0	.	.	262	264	TCC	490	492	TCC	206;206;205	T;C;C,G	194;194;191,1	parC.WHO_M_00204c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	539	4536	parE	1986	1986	99.95	parE.l15.c17.ctg.1	2520	179.2	0	.	p	.	0	R427H	NONSYN	1279	1281	CGC	1518	1520	CAC	225;225;226	C;A;C	201;202;203	.	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	539	4536	parE	1986	1986	99.95	parE.l15.c17.ctg.1	2520	179.2	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1467	1469	GGC	214;213;213	G;G;C	199;196;195	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.44.001	penA.44.001	1	1	27	4424	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2379	185.2	1	SNP	p	A311V	0	.	.	931	933	GCA	1300	1302	GCA	244;247;249	G;C;A	225;227;227	penA.44.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.44.001	penA.44.001	1	1	27	4424	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2379	185.2	1	SNP	p	I312M	0	.	.	934	936	ATC	1303	1305	ATC	251;251;253	A;T;C	228;228;230	penA.44.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.44.001	penA.44.001	1	1	27	4424	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2379	185.2	1	SNP	p	V316P	0	.	.	946	948	GTG	1315	1317	GTG	252;252;256	G;T;G	224;224;228	penA.44.001:1:1:V316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.44.001	penA.44.001	1	1	27	4424	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2379	185.2	1	SNP	p	V316T	0	.	.	946	948	GTG	1315	1317	GTG	252;252;256	G;T;G	224;224;228	penA.44.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.44.001	penA.44.001	1	1	27	4424	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2379	185.2	1	SNP	p	T484S	0	.	.	1450	1452	ACC	1819	1821	ACC	195;194;193	A;C;C	176;179;177	penA.44.001:1:1:T484S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.44.001	penA.44.001	1	1	27	4424	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2379	185.2	1	SNP	p	T502V	0	.	.	1504	1506	ACG	1873	1875	ACG	190;190;190	A;C;G	145;153;153	penA.44.001:1:1:T502V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.44.001	penA.44.001	1	1	27	4424	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2379	185.2	1	SNP	p	T502P	0	.	.	1504	1506	ACG	1873	1875	ACG	190;190;190	A;C;G	145;153;153	penA.44.001:1:1:T502P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.44.001	penA.44.001	1	1	27	4424	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2379	185.2	1	SNP	p	G543S	0	.	.	1627	1629	GGC	1996	1998	GGC	196;193;194	G;G;C	164;163;165	penA.44.001:1:1:G543S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.44.001	penA.44.001	1	1	27	4424	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2379	185.2	1	SNP	p	G546S	0	.	.	1636	1638	GGC	2005	2007	GGC	193;189;188	G;G;C	164;156;158	penA.44.001:1:1:G546S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.44.001	penA.44.001	1	1	27	4424	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2379	185.2	1	SNP	p	L552S	0	.	.	1654	1656	CTG	2023	2025	CTG	194;201;198	C,G;T,G;GCCC,GCCCC	142,6;145,1;133,2	penA.44.001:1:1:L552S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	6270	ponA	2397	2397	100.0	ponA.l15.c4.ctg.1	3110	201.0	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1648	1650	CCG	238;239;236	C;C,A;G	211;216,1;207	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2510	porA	1146	1146	99.65	porA.l15.c4.ctg.1	1746	142.9	0	.	p	.	0	M83fs	FSHIFT	247	247	A	505	505	C	212	C	193	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	292	porB1a	984	246	90.4	porB1a.l15.c30.ctg.2	252	37.3	0	.	p	.	0	V226A	NONSYN	676	678	GTA	4	6	GCA	14;14;14	G;C;A	4;4;4	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	292	porB1a	984	246	90.4	porB1a.l15.c30.ctg.2	252	37.3	0	.	p	.	0	.	MULTIPLE	700	702	ACT	27	29	GTA	15;15;14	G;T;A	7;7;7	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	292	porB1a	984	246	90.4	porB1a.l15.c30.ctg.2	252	37.3	0	.	p	.	0	N237fs	FSHIFT	709	709	A	36	36	A	14	A	7	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	27	2824	porB1b	1038	1038	100.0	porB1b.l15.c4.ctg.1	1662	169.1	1	SNP	p	G120K	1	.	.	358	360	AAG	694	696	AAG	215;214;212	A;A;G	199;198;197	porB1b.WHO_Y_02277c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	27	2824	porB1b	1038	1038	100.0	porB1b.l15.c4.ctg.1	1662	169.1	1	SNP	p	A121N	1	.	.	361	363	AAC	697	699	AAC	210;212;213	A;A;C	194;195;196	porB1b.WHO_Y_02277c:1:1:A121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	27	2824	porB1b	1038	1038	100.0	porB1b.l15.c4.ctg.1	1662	169.1	1	SNP	p	N121D	0	.	.	361	363	AAC	697	699	AAC	210;212;213	A;A;C	194;195;196	porB1b.WHO_Y_02277c:1:1:N121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_F_02153c	rpoB.WHO_F_02153c	1	1	27	11106	rpoB	4179	4179	100.0	rpoB.l15.c17.ctg.1	4802	230.7	1	SNP	p	H553N	0	.	.	1657	1659	CAT	1948	1950	CAT	273;275;275	C,A;A;T	252,1;257;257	rpoB.WHO_F_02153c:1:1:H553N:rpoB.553N:H552N. High-level resistance to Rifampicin	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	1178	rpsJ	312	312	100.0	rpsJ.l15.c4.ctg.1	919	126.8	1	SNP	p	V57M	1	.	.	169	171	ATG	454	456	ATG	253;255;259	A;T;G,A	228;227;231,1	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
